Although primary breast cancer tumors were examined in these clinical datasets for expression levels of TDO2, AhR, and ZEB1, these genes may be expressed at even higher levels in circulating tumor cells (anchorage-independent condition). This evidence concerns the gene ZEB1 and breast cancer.